CAMBRIDGE, Mass., April 11, 2024 /PRNewswire/ — Akamai Technologies, Inc. (NASDAQ: AKAM), the cloud company that powers and protects life online, announced today that the company will hold a conference call for investors on Thursday, May 9, 2024, at 4:30 p.m. ET. The call will include the company’s first quarter 2024 financial results and may… Continue reading Akamai Technologies To Hold First Quarter 2024 Investor Conference Call On Thursday, May 9, at 4:30 PM ET
Author: PR Newswire Online News
Corero Network Security Enters New Relationship with TierPoint
MARLBOROUGH, Mass., April 11, 2024 /PRNewswire/ — Today, Corero Network Security (AIM: CNS, OTC: DDOSF), the distributed denial of service (DDoS) protection specialists, announces its new partnership with TierPoint. This new relationship marks a significant achievement, showcasing the superior capabilities and value of Corero’s DDoS protection offerings. TierPoint has selected Corero Network Security for its next-generation… Continue reading Corero Network Security Enters New Relationship with TierPoint
DOCUSIGN UNVEILS NEW AI-POWERED “INTELLIGENT AGREEMENT MANAGEMENT” PLATFORM FOR NEW SAAS CATEGORY
Docusign IAM helps business recapture annual $2T in lost global economic value* SAN FRANCISCO, April 11, 2024 /PRNewswire/ — Docusign (NASDAQ: DOCU) today announced a significant expansion of its company strategy, opening up a new SaaS category — Intelligent Agreement Management — and unveiling Docusign IAM, an Intelligent Agreement Management platform and suite of applications… Continue reading DOCUSIGN UNVEILS NEW AI-POWERED “INTELLIGENT AGREEMENT MANAGEMENT” PLATFORM FOR NEW SAAS CATEGORY
Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity
LPCN 2401 treatment resulted in statistically significant body composition improvement in men Increased lean mass (LM) by 4.4% and decreased fat mass (FM) by 6.7% Reduced android fat (AF) by 4.1% and increased bone mineral content (BMC) by 2.8% Well-tolerated, adverse events (AEs) similar to placebo Potential for use in combination with incretin mimetics (GLP-1/GIP… Continue reading Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity
Pharmaceutical Innovation Drives Steady 8.70% CAGR for Injectable Drug Delivery Systems Market: Future Market Insights
According to FMI, The injectable drug delivery market is booming, driven by a surge in chronic diseases and a growing need for efficient treatment methods. Fueled by telemedicine integration and pharmaceutical innovation, reflecting a steady growth of 8.7% annually. This trend is pushing pharmaceutical companies to develop better devices for managing chronic illnesses, ultimately shaping… Continue reading Pharmaceutical Innovation Drives Steady 8.70% CAGR for Injectable Drug Delivery Systems Market: Future Market Insights
World leading carbon ion center QST in Japan selects RayStation
STOCKHOLM, April 11, 2024 /PRNewswire/ — RaySearch Laboratories AB (publ) announces that QST, National Institutes for Quantum Science and Technology in Chiba, Japan, has selected the treatment planning system RayStation®* for clinical use at the QST hospital. The order was received and delivered in the first quarter of 2024. Already in 2018 RaySearch and NIRS… Continue reading World leading carbon ion center QST in Japan selects RayStation
Net5.5G Application Deployment Achieves Remarkable Progress, Inspiring Carriers’ New Growth
PARIS, April 11, 2024 /PRNewswire/ — The IP GALA Summit themed “Bring Net5.5G into Reality, Inspire New Growth” was successfully held by Huawei during the MPLS SD & AI Net World Congress 2024. The summit brought together guests from carriers, standards organizations, and industry organizations, to discuss major topics such as Net5.5G application deployment, scenario innovation,… Continue reading Net5.5G Application Deployment Achieves Remarkable Progress, Inspiring Carriers’ New Growth
Smarsh Bolsters Board of Directors with New Additions
Experienced tech and financial services executives Lynn Danko, Sagnik Nandy and Tim Scheve to help steer fast-growing category leader through next phase of growth PORTLAND, Ore., April 11, 2024 /PRNewswire/ — Smarsh, the global leader in digital communications compliance and intelligence, today welcomed proven business leaders, Sagnik Nandy and Tim Scheve, to its board of… Continue reading Smarsh Bolsters Board of Directors with New Additions
Matthew Gotlin Named Choreo’s Chief Investment Officer
Appointment Part of Investment Team Expansion Aimed at Delivering Tax Efficient and Technology-Enabled Public and Private Market Investments and Research CHICAGO, April 11, 2024 /PRNewswire/ — Choreo, LLC (“Choreo” or “the firm”) announced today that it has named Matthew Gotlin, CFA®, its Chief Investment Officer. Gotlin will lead a team that will continue to create… Continue reading Matthew Gotlin Named Choreo’s Chief Investment Officer
West to Host First-Quarter 2024 Conference Call
EXTON, Pa., April 11, 2024 /PRNewswire/ — West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter financial results before the market opens on Thursday, April 25, 2024, and will follow with a conference call to discuss the results and business expectations at… Continue reading West to Host First-Quarter 2024 Conference Call